Exosome/staphylococcal enterotoxin B, an anti tumor compound against pancreatic cancer

Journal of B.U.ON.

Volumn 19, Issue 2, 2014, Pages 440-448

  Hosseini, Hamideh Mahmoodzadeh ^a   Fooladi, Abbas Ali Imani ^b   Soleimanirad, Jafar ^c   Nourani, Mohammad Reza ^b   Mahdavi, Mehdi ^d  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d PASTEUR INSTITUTE OF IRAN   (Iran)

Author keywords

Apoptosis; Exosome; Pancreatic cancer; Staphylococcal enterotoxin B

Indexed keywords

CASPASE 3; CASPASE 9; FAS ANTIGEN; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL; STAPHYLOCOCCUS ENTEROTOXIN B;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; APOPTOSIS ASSAY; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG SYNTHESIS; EMBRYO; ENZYME ACTIVITY; EXOSOME; GENE EXPRESSION; HUMAN; HUMAN CELL; MTT ASSAY; PANCREAS CANCER; PANCREAS CELL; PROTEIN EXPRESSION; PROTEIN TRANSPORT; PURIFICATION; STAINING;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CASPASE 3; CASPASE 9; CELL LINE, TUMOR; DOSE-RESPONSE RELATIONSHIP, DRUG; ENTEROTOXINS; EXOSOMES; HUMANS; PANCREATIC NEOPLASMS;

EID: 84904185940     PISSN: 11070625     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Siegel R, Ward E, Brawley O, Jemal A. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 2011;61:212-236.
2. Koido S, Homma S, Takahara A et al. Current immunotherapeutic approaches in pancreatic cancer. Clin Dev Immunol 2011;2011:267539.
3. Rieger J, Freichels H, Imberty A et al. Polyester nanoparticles presenting mannose residues: toward the development of new vaccine delivery systems combining biodegradability and targeting properties. Biomacromolecules 2009,10:651-657.
4. Hosseini HM, Fooladi AA, Nourani MR, Ghanezadeh F. Role of exosome in infectious disease. Inflamm Allergy Drug Targets 2013; 12: 29-37.
5. Schorey JS, Bhatnagar S. Exosome function: from tumor immunology to pathogen biology. Traffic 2008; 9:871-881. (Pubitemid 351639493)
6. Cho JA, Yeo DJ, Son HY et al. Exosomes: a new delivery system for tumor antigens in cancer immunotherapy. Int J Cancer 2005;114:613-622.
7. Tan A, De La Peña H, Seifalian AM. The application of exosomes as a nanoscale cancer vaccine. Int J Nanomed 2010;5:889-900.
8. Ristorcelli E, Beraud E, Mathieu S, Lombardo D, Verine A. Essential role of Notch signaling in apoptosis of human pancreatic tumor cells mediated by exosomal nanoparticles. Int J Cancer 2009;125:1016-1026.
9. Ristorcelli E, Beraud E, Verrando P et al. Human tumor nanoparticles induce apoptosis of pancreatic cancer cells. FASEB J 2008;22:3358-3369.
10. Choi YW, Kotzin B, Herron L, Callahan J, Marrack P Kappler J. Interaction of Staphylococcus aureus toxin" superantigens" with human T cells. Proc Natl Acad Sciences 1989;86:8941-8945. (Pubitemid 20010341)
11. Kappler J, Kotzin B, Herron L et al. V beta-specific stimulation of human T cells by staphylococcal toxins. Science 1989;244:811-813. (Pubitemid 19163867)
12. Imani Fooladi AA, Sattari M, Hassan ZM, Mahdavi M, Azizi T, Horii A. In vivo induction of necrosis in mice fibrosarcoma via intravenous injection of type B staphylococcal enterotoxin. Biotechnol Lett 2008;30:2053-2059.
13. Imani Fooladi AA, Sattari M, Nourani MR. Synergistic effects between staphylococcal enterotoxin type B and monophosphoryl lipid A against mouse fibrosarcoma. JBUON 2010;15: 340-347.
14. Fooladi AAI, Sattari M, Nourani MR. Study of T-cell stimulation and cytokine release induced by staphylococcal enterotoxin type B and monophosphoryl lipid A. Arch Med Sci 2009;3:335-341.
15. Higgs BW, Dileo J, Chang WE et al. Modeling the effects of a staphylococcal enterotoxin B (SEB) on the apoptosis pathway. BMC Microbiol 2006;6:48-60.
16. Battke C, Ruiss R, Welsch U et al. Tumour exosomes inhibit binding of tumour-reactive antibodies to tumour cells and reduce ADCC. Cancer Immunol Immunother 2011;60:639-648.
17. Exosome protein and RNA database. ExoCarta 2010 [cited 2010]. Available from: http://exocarta.ludwig.edu.au.
18. McHugh RS, Nagarajan S, Wang YC, Sell KW, Selvaraj P. Protein transfer of glycosyl-phosphatidylinositol-B7-1 into tumor cell membranes: a novel approach to tumor immunotherapy. Cancer Res 1999:59:2433-2437. (Pubitemid 29242293)
19. Oltvai ZN, Milliman CL, Korsmeyer SJ. Bcl-2 hecerodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 1993;74:609-619. (Pubitemid 23259742)
20. Fadeel B, Orrenius S. Apoptosis: a basic biological phenomenon with wide-ranging implications in human disease. J Intern Med 2005;258:479-517. (Pubitemid 41705391)
21. Ferenbach DA, Haydon GH, Rae F, Malcomson RD, Harrison DJ. Alteration in mRNA levels of Fas splice variants in hepatitis C-infected liver. J Pathol 1997;183:299-304. (Pubitemid 27505215)
22. Marone M, Mozzetti S, De Ritis D, Pierelli L, Scambia G. Semiquantitative RT-PCR analysis to assess the expression levels of multiple transcripts from the same sample. Biol Proced Online 2001;3:19-25. (Pubitemid 33807179)
23. Chen JH, Cao JL, Chu YL, Wang ZL, Yang ZT, Wang HL T-2 toxin-induced apoptosis involving Fas, p53, Bcl-xL, Bcl-2, Bax and caspase-3 signaling pathways in human chondrocytes. J Zhejiang Univ Sci B 2008; 9:455-463.
24. Kim H, Chung H, Kim HJ et al. Id-1 regulates Bcl-2 and Bax expression through p53 and NF-kappaB in MCF-7 breast cancer cells. Breast Cancer Res Treat 2008;112:287-296.
25. Banisor I, Kalman B. Bcl-2 and its homologues in the brain of patients with multiple sclerosis. Mult Scler 2004;10:176-181. (Pubitemid 38499911)
26. Khaheshi I, Keshavarz S, Imani Fooladi AA et al. Loss of expression of TGF-βs and their receptors in chronic skin lesions induced by sulfur mustard as compared with chronic contact dermatitis patients. BMC Dermatol 2011;11:2-10.